For World Mental Health Day, Ian Bolland and Reece Armstrong speak to former health minister Sir Norman Lamb about his recent appointment to XenZone and the availability of mental health services in the UK.
Orlando Agrippa, founder and CEO of healthcare analytics company Draper & Dash writes about how data can be used by pharma companies to demonstrate value.
Chris Johnson, managing director of ceramic bearings supplier SMB Bearings investigates why a stringent approach to containment doesn’t always translate into plant maintenance.
Arne Rehm, product manager RFID/NFC Solutions at Schreiner MediPharm, explains how smart labels with integrated RFID/NFC chips support digitalisation trends in the pharmaceutical industry.
Graham Francis, product marketing manager at Kallik writes about how new technologies are helping pharma companies keep up with changing labelling regulations.
European Pharmaceutical Manufacturer editor Reece Armstrong sits down with World Courier president Sam Herbert to discuss the complexity of the pharma supply chain and the role the company has played on the industry’s world stage.
We are now six months passed the EU FMD deadline and various organisations like EMVO have begun to ask the authorities to take out sanctions against companies that don’t comply with the FMD regulations.
The rise of artificial intelligence has been popular within the life sciences industry and in particular pharma. Find out why and what it means for the future of drug development.
Oliver Leatham, vice president and global head of value and access at Certara, writes about the complex issues that surrounds assigning a value to new drugs.
Lola Yomi-Baker is product manager at BioPure Technology - part of Watson-Marlow Fluid Technology Group. Having studied biochemistry and biochemical engineering, she has worked in a number of bioengineering roles.
